Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
Clinical trial NCT03296696 · TERMINATED
Trial details
- NCT number
- NCT03296696
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2021-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.